mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.01 |
mRNA |
GSK525762A |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.02 |
mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
-0.072 |
0.02 |
mRNA |
ruxolitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.078 |
0.02 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.02 |
mRNA |
GSK269962A |
GDSC1000 |
pan-cancer |
AAC |
-0.074 |
0.02 |
mRNA |
Lisitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.078 |
0.02 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.02 |
mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.02 |
mRNA |
tubastatin A |
GDSC1000 |
pan-cancer |
AAC |
-0.069 |
0.02 |